Clinical Trials Directory

Trials / Unknown

UnknownNCT00000350

Effects of Stimulant Dependence on Human Striatal Dopamine System - 15

Effects of Stimulant Dependence on Human Striatal Dopamine System

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
0 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether DAT availability, assessed by WIN binding, in the striatum is altered in cocaine or methamphetamine dependence. To determine whether DA synthesis capacity, assessed by FDOPA uptake, in the striatum is altered in Coc or Meth dependence. To determine whether the PET tracers, WIN or FDOPA, will differentiate Meth induced alterations from those induced by Coc use. To determine whether the PET characterization of striatal alterations observed at 3-5 days since last drug use persists at least 3 months after last drug use.

Detailed description

4-5 Day inpatient study. Participant will have scanned pictures (MRI \& PET scans) taken of their brain after being injected with a small amount of WIN, a radioactive substance. Participants give daily urine samples and fill out health related questionnaires. It is important to determine whether the alterations characterized within one week of last drug use persist over a longer time period. Based on results of the studies from aims 1 \& 2, we will decide which of the 2 probes, WIN or FDOPA-PET is the more sensitive index of stimulant-dependency-induced changes.

Conditions

Interventions

TypeNameDescription
PROCEDUREradioactive substance

Timeline

Start date
1999-03-01
First posted
1999-09-21
Last updated
2017-01-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000350. Inclusion in this directory is not an endorsement.